Valley News -

Mayo Clinic researchers ID potential new treatment for one type of triple-negative breast cancer

 

Last updated 10/12/2018 at 1:45am



ROCHESTER, Minn. – Mayo Clinic researchers have identified the drug estradiol as a potential new treatment for a subset of women with triple-negative breast cancer. Their findings are published in the Proceedings of the National Academy of Sciences of the United States of America.

“Triple-negative breast cancer is a form of breast cancer that lacks expression of estrogen receptor alpha, progesterone receptor and human epidermal growth factor receptor 2, also known as HER2. And it exhibits high rates of disease recurrence,” Dr. John Hawse, a molecular biologist at Mayo Clinic and sen...



For access to this article please sign in or subscribe.



 

Reader Comments
(0)

 
 

Our Family of Publications Includes:

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2018